How risky is SMR stock?

``` The deep research logic is organized as follows: Okay, let's tackle the question: "How risky is SMR stock?" First, I need to gather all the relevant data from the provided references and background. The user is asking about the risk level, so I should focus on financial metrics, analyst ratings, market trends, and recent events that impact risk. Starting with the latest report period, Reference 1 shows that SMR's latest report is for 2025Q3. The risk rating from Reference 2 has multiple ratings from different dates in 2025Q3, including Sell, Neutral, and Strong Buy. That's a bit conflicting, so I need to note the variability in analyst opinions. Looking at the financials, Reference 3 mentions a significant loss in Q3 2025, with revenue missing expectations and a net loss per share of $1.85. The debt-to-equity ratio from References 8 and 9 shows that as of 2025Q3, the ratio was 1.03, which is moderate but higher than previous quarters. However, Reference 14 mentions a debt-to-equity ratio of 0, which might be conflicting data. I need to clarify that. The stock price has been volatile, as seen in References 3 and 17, with a beta of 2.86, indicating high volatility. The price trend forecasts from References 25, 27, and 29 suggest a bearish trend with a sell recommendation. The support and resistance levels are also bearish, with the current price below the wide support level. Analyst consensus from Reference 23 shows a majority rating of Neutral, but recent downgrades from analysts like Citi and UBS (References 14, 15, 18, 19) have lowered price targets and expressed concerns about revenue generation and contract risks. Institutional activity shows mixed signals: some institutions like Virtu Financial are buying (References 4, 10), while others like Fluor are selling (References 3, 18, 19). Market sentiment is negative, with the stock price dropping 7.7% recently (Reference 3) and a consensus rating of "Reduce" (Reference 20). The company faces execution risks, regulatory challenges, and competition in the SMR market (References 3, 14, 33). However, there's potential upside with upcoming projects like the TVA contract (References 4, 7, 32). Putting this all together, SMR has high operational and financial risks due to losses, high debt, and execution uncertainties. The stock is volatile with a bearish trend, but there are strategic partnerships and regulatory approvals that could mitigate some risks. The mixed analyst ratings and institutional activity add to the uncertainty. The user's profile suggests they value balanced analysis, so I should present both the risks and potential upside clearly. ``` ### 🚨 **Conclusion** NuScale Power (SMR) presents **high operational and financial risks** due to its recent financial underperformance, regulatory uncertainties, and high volatility. However, its **strategic partnerships** and **regulatory approvals** offer potential upside for long-term investors. The stock is **bearish in the short term** but could stabilize if it secures its first commercial contracts by 2026 . --- ### 📊 **Risk Analysis Breakdown** #### 1. **Financial Health** | Metric | Value (2025Q3) | Risk Implication | |----------------------------|--------------------------|----------------------------------------------------------------------------------| | **Revenue** | $8.2M (vs. $11.2M forecast) | **Missed expectations** by 29%, signaling execution challenges. | | **Net Loss** | $1.85 per share | **Deep losses** persist, raising concerns about near-term profitability. | | **Debt-to-Equity Ratio** | 1.03 | **Moderate leverage**, but higher than historical averages (median: 0.19 ). | | **Liquidity** | $753.8M | **Adequate runway** for operations, but no debt-free buffer . | #### 2. **Market Sentiment & Analyst Ratings** | Metric | Data (2025Q3–2025Q4) | Risk Implication | |----------------------------|---------------------------|----------------------------------------------------------------------------------| | **Analyst Consensus** | Neutral (majority) | **Mixed outlook**: 3 Buy, 7 Hold, 6 Sell ratings . | | **Price Target** | $36.12 (average) | **Bearish bias**: Recent downgrades (Citi, UBS) cut targets by 50% . | | **Institutional Activity** | 78.37% ownership | **Conflicting signals**: Virtu Financial buys (+1.16% stake ), Fluor sells (-$104M ). | #### 3. **Operational Risks** | Risk Factor | Details (2025Q3–2025Q4) | Impact on Risk Profile | |----------------------------|---------------------------|----------------------------------------------------------------------------------| | **Project Delays** | Carbon Free Power Project canceled | **Existential crisis** for SMR adoption; no commercial contracts yet . | | **Regulatory Hurdles** | NRC approval for 77 MW upgrade | **Positive**: Only U.S. SMR approved, but **execution risks** remain . | | **Competition** | Oklo (OKLO) market cap: $12B | **Pressure**: NuScale ($5B market cap) faces stiff competition . | #### 4. **Market Volatility** | Metric | Data (2025Q4) | Risk Implication | |----------------------------|---------------------------|----------------------------------------------------------------------------------| | **Beta** | 2.86 | **High volatility**: 3x market sensitivity . | | **Price Trend** | Bearish (11-day duration) | **Short-term risk**: 67% chance of continued bearish trend . | | **Support/Resistance** | Below wide support (16.07) | **Bearish signal**: Current price ($15.79) near breakdown level . | --- ### 🌟 **Key Takeaways** - **Short-term Risk**: High volatility, execution risks, and analyst downgrades make SMR a **speculative play**. - **Long-term Potential**: Regulatory approvals and partnerships (e.g., TVA, RoPower) could unlock **strategic upside** by 2026 . - **Investor Strategy**: **Hold for high-risk tolerance**; monitor liquidity, contract signings, and institutional activity closely .